13F-HR filed by Atle Fund Management AB
Atle Fund Management AB filed this 13F-HR for the quarter ended 2016-03-31, filed 2016-04-19, with 18 holding rows worth $213,575,000.
- Accession
- 0000950123-16-015863
- Filer
- CIK 1381843
- Filed
- 2016-04-19
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2016
A holdings report, 18 entries on the cover page, a total value of $213,575,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $213,576,000 with VALUE read as thousands by filing date, 13F file number 028-12171. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ANIKA THERAPEUTICS INC | 035255108 | COM | 490,331 | $21,928,000 | thousands by filing date | |
| FEI CO | 30241L109 | COM | 239,609 | $21,328,000 | thousands by filing date | |
| LIFEPOINT HEALTH INC | 53219L109 | COM | 274,430 | $19,004,000 | thousands by filing date | |
| GNC HLDGS INC | 36191G107 | COM CL A | 586,955 | $18,636,000 | thousands by filing date | |
| AMAG PHARMACEUTICALS INC | 00163U106 | COM | 740,585 | $17,330,000 | thousands by filing date | |
| SUPERNUS PHARMACEUTICALS | 868459108 | COM | 903,533 | $13,779,000 | thousands by filing date | |
| CHARLES RIV LABS INTL INC | 159864107 | COM | 178,307 | $13,541,000 | thousands by filing date | |
| TARO PHARMACEUTICAL INDS LTD | M8737E108 | SHS | 94,005 | $13,466,000 | thousands by filing date | |
| INC RESH HLDGS INC | 45329R109 | CL A | 324,270 | $13,363,000 | thousands by filing date | |
| Merck & Co.,Inc. | 58933Y105 | COM | 251,400 | $13,302,000 | thousands by filing date | |
| Elevance Health, Inc. | 036752103 | COM | 93,900 | $13,051,000 | thousands by filing date | |
| TRIPLE-S MGMT CORP | 896749108 | CL B | 503,826 | $12,525,000 | thousands by filing date | |
| VALEANT PHARMACEUTICALS INTL | 91911K102 | COM | 370,000 | $9,731,000 | thousands by filing date | |
| SYMMETRY SURGICAL INC | 87159G100 | COM | 316,427 | $3,120,000 | thousands by filing date | |
| ORASURE TECHNOLOGIES INC | 68554V108 | COM | 405,771 | $2,934,000 | thousands by filing date | |
| DEPOMED INC | 249908104 | COM | 200,000 | $2,786,000 | thousands by filing date | |
| SCICLONE PHARMACEUTICALS INC | 80862K104 | COM | 236,288 | $2,599,000 | thousands by filing date | |
| IMMUCELL CORP | 452525306 | COM PAR | 168,323 | $1,153,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000950123-16-015863 | this filing | 2016-04-19 | acceptance time not in the bulk data set |